Skip to main content
Leiden University
Scholarly Publications
Home
Submit
About
Select Collection
All collections
Academic speeches
Dissertations
Faculty of Archaeology
Faculty of Governance and Global Affairs
Faculty of Humanities
Faculty of Science
Faculty of Social and Behavioural Sciences
Leiden Journals, Conference Proceedings and Books
Leiden Law School
Leiden University Press
Medicine / Leiden University Medical Centre (LUMC)
Research output UL
Search box
Your Search
Enabled Filters
(-)
= Wong, D.A.
Sort Options
Date (year)
Author / Creator
Title
Refine Results
Resource Type
Article / Letter to editor
(6)
+
-
Availability
Metadata Only
(6)
+
-
Creation Date
2015
(4)
+
-
2016
(2)
+
-
Faculty
Leiden University Medical Center (LUMC)
(6)
+
-
Collection
Medicine / Leiden University Medical Centre (LUMC)
(6)
+
-
Author
Bykerk, V.P.
(6)
+
-
Combe, B.G.
(6)
+
-
Emery, P.
(6)
+
-
Furst, D.E.
(6)
+
-
Huizinga, T.W.J.
(6)
+
-
Wong, D.A.
(6)
+
-
Burmester, G.R.
(5)
+
-
Karyekar, C.S.
(3)
+
-
DiCarlo, J.C.
(2)
+
-
Peterfy, C.
(2)
+
-
Show more
Language
en
(6)
+
-
Search results
(1 - 6 of 6)
show grid
show list
save search
Sustained improvements in MRI outcomes with abatacept following the withdrawal of all treatments in patients with early, progressive rheumatoid arthritis
ON DRUG AND DRUG-FREE REMISSION BY BASELINE DISEASE DURATION: ABATACEPT VERSUS METHOTREXATE COMPARISON IN PATIENTS WITH EARLY RHEUMATOID ARTHRITIS
Effect of Anti-Cyclic Citrullinated Peptide 2 Immunoglobulin M Serostatus on Efficacy Outcomes Following Treatment with Abatacept Plus Methotrexate
SUSTAINED IMPROVEMENTS IN MAGNETIC RESONANCE IMAGING OUTCOMES WITH ABATACEPT FOLLOWING THE WITHDRAWAL OF ALL TREATMENT IN PATIENTS WITH EARLY RHEUMATOID ARTHRITIS
PREDICTORS OF DRUG-FREE REMISSION FOLLOWING TREATMENT WITH ABATACEPT (IN COMBINATION WITH METHOTREXATE OR AS MONOTHERAPY) IN EARLY RHEUMATOID ARTHRITIS
Evaluating drug-free remission with abatacept in early rheumatoid arthritis: results from the phase 3b, multicentre, randomised, active-controlled AVERT study of 24 months, with a 12-month, double-blind treatment period